Skip to main content
European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

A ground-breaking biomolecular production platform for safer, more efficient and sustainable pest control and crop health management

Descripción del proyecto

Cultivos protegidos gracias a unos productos innovadores

La dependencia de los fertilizantes químicos en la agricultura perjudica al medio ambiente, lo que pone de manifiesto la necesidad de alternativas como los bioplaguicidas. Su preferencia sobre los plaguicidas ha motivado un aumento de la demanda de moléculas de origen biológico. La empresa emergente francesa LIPOFABRIK ha desarrollado y patentado una metodología de producción de micosubtilina, un lipopéptido natural producido por la bacteria «Bacillus subtilis» cuyos efectos antifúngicos y estimulantes se han probado en varios cultivos. Además, la empresa ha desarrollado otro producto con actividad bioestimulante. El objetivo del proyecto financiado con fondos europeos Lipofabrik es solventar la actual escasez de este tipo de biomoléculas en el mercado. Para ello, se industrializará el proceso de formulación y producción, lo que favorecerá la producción masiva a precios competitivos.

Objetivo

LIPOFABRIK is an innovative start-up from the University of Lille, specialized in the production of biological molecules with application in the phytosanitary, food, cosmetic and medical cleaning markets. Our specialised team of researchers has developed and patented a production methodology for mycosubtilin, a bioactive lipopeptide produced by Bacillus subtilis with demonstrated antifungal and stimulating effects in several crops. Since 2013, LIPOFABRIK holds exclusivity on this patent, focused now on its market exploitation and IP portfolio expansion.
LIPOFABRIK has invested over 5 years and €2.18 million in the development, validation and business preparation of mycosubtilin for application as biopesticide and biostimulant. We have demonstrated the safety, efficiency and effectiveness of mycosubtilin against fungal infections in open field and greenhouses, reporting the superior efficacy in several peer review publications.
We have a lipopeptide production plant in pilot stage, yielding 50 kg per year. In views of the ongoing market demand, regulatory requirements and unmet needs faced by manufacturers of plant protection products, we aim to industrialise our production line responding to the market demand at a cost-efficient price. LIPOFABRIK aims to produce at quantities 10 times higher, with prices 5 times lower and higher purity than competitors offer.
This project aims to overcome the current market shortage on lipopeptides, industrialising our proprietary formulation and process to be aligned with the voiced demand. Upon completion, we will operate the first industrial lipopeptide production plant in Europe, providing a sustainable and cost-efficient solution for natural plant protection. Our proprietary biopesticide ingredients will be sold at a competitive price, being the only European company with capability to deliver bulk amounts, from 200-400 tons per year, of lipopeptides needed for large scale application in agriculture and gardening.

Convocatoria de propuestas

H2020-EIC-SMEInst-2018-2020

Consulte otros proyectos de esta convocatoria

Convocatoria de subcontratación

H2020-SMEInst-2018-2020-2

Régimen de financiación

SME-2 - SME instrument phase 2

Coordinador

LIPOFABRIK
Aportación neta de la UEn
€ 1 586 345,25
Dirección
UNIVERSITE LILLE 1 POLYTECH LILLE AVENUE PAUL LANGEVIN
59655 VILLENEUVE D'ASCQ
Francia

Ver en el mapa

Pyme

Organización definida por ella misma como pequeña y mediana empresa (pyme) en el momento de la firma del acuerdo de subvención.

Región
Hauts-de-France Nord-Pas de Calais Nord
Tipo de actividad
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Enlaces
Coste total
€ 2 266 207,50